Manufacturing News Novo Nordisk Invests €432 Million in Ireland to Expand Oral GLP-1 Manufacturing Capacity 2 March 2026
Expert Insight Novo Nordisk CEO: We Were ‘Cursed as a Leader’ as Lilly Closes GLP-1 Gap 19 January 2026
Manufacturing News Novo Nordisk wins FDA approval for oral Wegovy, launching first GLP-1 pill for obesity 23 December 2025
Manufacturing News Novo Nordisk, Pfizer Bidding War for Metsera Escalates to $10 Billion as FTC Raises Concerns 6 November 2025